| |
|
|
| Name: |
BAKER BROS ADVISORS LLC |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10021 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
99 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
BGNE |
Beigene Ltd |
1 |
- |
$322.90 |
$2,997,837,000 |
8,799,053 |
21.73% |
867,850,000 |
0 |
9.709 |
N/A |
|
|
INCY |
Incyte Corp |
2 |
- |
$102.52 |
$2,607,370,000 |
30,743,663 |
18.9% |
513,753,000 |
388 |
14.038 |
Biotechnology |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
3 |
- |
$577.30 |
$982,313,000 |
2,141,701 |
7.12% |
384,291,000 |
165,683 |
8.33 |
Diagnostic Substances |
|
|
INSM |
Insmed Inc |
4 |
- |
$204.00 |
$965,369,000 |
6,703,484 |
7% |
189,143,000 |
-1,009,416 |
3.171 |
Biotechnology |
|
|
ACAD |
Acadia Pharmaceuticals Inc |
5 |
- |
$27.44 |
$915,415,000 |
42,896,690 |
6.63% |
-9,867,000 |
0 |
23.827 |
Biotechnology |
|
|
SMMT |
Summit Therapeutics Inc |
6 |
- |
$18.31 |
$696,717,000 |
33,722,974 |
5.05% |
-20,908,000 |
0 |
4.812 |
N/A |
|
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
7 |
- |
$104.60 |
$565,997,000 |
5,604,483 |
4.1% |
211,850,000 |
0 |
7.901 |
N/A |
|
|
RVMD |
Revolution Medicines, Inc. |
8 |
- |
$79.64 |
$441,565,000 |
9,455,357 |
3.2% |
97,028,000 |
90,385 |
4.714 |
N/A |
|
|
CELC |
Celcuity Inc. |
9 |
- |
$105.63 |
$391,040,000 |
7,915,792 |
2.83% |
318,277,000 |
2,465,347 |
21.377 |
N/A |
|
|
KYMR |
Kymera Therapeutics, Inc. |
10 |
- |
$0.00 |
$376,471,000 |
6,651,429 |
2.73% |
86,203,000 |
0 |
7.833 |
N/A |
|
|
KOD |
Kodiak Sciences Inc. |
11 |
- |
$24.34 |
$283,373,000 |
17,310,490 |
2.05% |
218,805,000 |
0 |
38.64 |
N/A |
|
|
ALKS |
Alkermes Plc |
12 |
- |
$29.52 |
$242,741,000 |
8,091,351 |
1.76% |
59,334,000 |
1,680,748 |
4.405 |
Drug Delivery |
|
|
ABCL |
Abcellera Biologics Inc. |
13 |
- |
$0.00 |
$138,454,000 |
27,525,640 |
1% |
44,041,000 |
0 |
10.225 |
N/A |
|
|
EWTX |
Edgewise Therapeutics, Inc. |
14 |
- |
$23.59 |
$118,502,000 |
7,305,940 |
0.86% |
22,721,000 |
0 |
5.842 |
N/A |
|
|
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
15 |
- |
$41.67 |
$109,682,000 |
2,824,669 |
0.79% |
31,523,000 |
0 |
6.983 |
N/A |
|
|
STOK |
Stoke Therapeutics, Inc. |
16 |
- |
$30.87 |
$108,895,000 |
4,633,838 |
0.79% |
56,301,000 |
0 |
7.044 |
N/A |
|
|
IMTX |
Immatics N.V |
17 |
- |
$10.18 |
$103,042,000 |
12,094,094 |
0.75% |
48,333,000 |
1,925,193 |
11.729 |
N/A |
|
|
GRAL |
Grail, Llc |
18 |
- |
$100.98 |
$96,389,000 |
1,630,125 |
0.7% |
12,568,000 |
0 |
5.242 |
N/A |
|
|
IDYA |
Ideaya Biosciences, Inc. |
19 |
- |
$0.00 |
$89,125,000 |
3,275,444 |
0.65% |
44,589,000 |
1,156,716 |
3.359 |
N/A |
|
|
IMVT |
Immunovant Inc |
20 |
- |
$0.00 |
$87,981,000 |
5,457,881 |
0.64% |
655,000 |
0 |
3.213 |
N/A |
|
|
IMCR |
Immunocore Holdings Adr |
21 |
- |
$38.78 |
$84,382,000 |
2,322,656 |
0.61% |
11,497,000 |
0 |
4.645 |
N/A |
|
|
BCYC |
Bicycle Therapeutics Ltd |
22 |
- |
$0.00 |
$84,253,000 |
10,885,357 |
0.61% |
8,600,000 |
0 |
15.778 |
N/A |
|
|
RARE |
Ultragenyx Pharmaceutical Inc |
23 |
- |
$36.38 |
$83,403,000 |
2,772,692 |
0.6% |
-17,412,000 |
0 |
2.882 |
Restaurants |
|
|
ABVX |
Abivax S.A |
24 |
New |
$114.51 |
$74,355,000 |
875,796 |
0.54% |
74,355,000 |
875,796 |
1.413 |
N/A |
|
|
ARWR |
Arrowhead Pharmaceuticals Inc |
25 |
- |
$61.44 |
$57,625,000 |
1,670,762 |
0.42% |
42,786,000 |
731,588 |
1.21 |
Business Services |
|
|
ROIV |
Roivant Sciences Ltd. |
26 |
- |
$20.97 |
$57,006,000 |
3,767,773 |
0.41% |
14,543,000 |
0 |
0.544 |
N/A |
|
|
DNLI |
Denali Therapeutics Inc. |
27 |
- |
$19.96 |
$54,184,000 |
3,731,695 |
0.39% |
1,978,000 |
0 |
2.61 |
N/A |
|
|
MRUS |
Merus Nv |
28 |
- |
$96.14 |
$54,078,000 |
574,377 |
0.39% |
23,866,000 |
0 |
0.759 |
N/A |
|
|
NTLA |
Intellia Therapeutics, Inc. |
29 |
- |
$9.61 |
$47,435,000 |
2,746,674 |
0.34% |
22,337,000 |
71,000 |
2.704 |
N/A |
|
|
REPL |
Replimune Group Inc |
30 |
- |
$10.61 |
$46,280,000 |
11,045,336 |
0.34% |
-56,331,000 |
0 |
12.832 |
N/A |
|
|
RAPP |
Rapport Therapeutics, Inc. |
31 |
- |
$29.50 |
$45,949,000 |
1,547,090 |
0.33% |
39,694,000 |
997,000 |
2.995 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
32 |
- |
$34.56 |
$43,571,000 |
1,556,109 |
0.32% |
-8,461,000 |
-952,658 |
2.47 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
33 |
- |
$32.02 |
$37,644,000 |
1,744,406 |
0.27% |
13,257,000 |
0 |
1.758 |
N/A |
|
|
IONS |
Ionis Pharmaceuticals Inc |
34 |
- |
$81.68 |
$37,080,000 |
566,798 |
0.27% |
37,080,000 |
566,798 |
0.326 |
Drug Manufacturers - ... |
|
|
PRAX |
Praxis Precision Medicines,... |
35 |
- |
$0.00 |
$36,543,000 |
689,488 |
0.26% |
7,550,000 |
0 |
1.316 |
N/A |
|
|
GLUE |
Monte Rosa Therapeutics, Inc. |
36 |
- |
$0.00 |
$36,428,000 |
4,916,095 |
0.26% |
14,256,000 |
0 |
7.581 |
N/A |
|
|
BNTX |
Biontech Se Adr |
37 |
- |
$0.00 |
$36,383,000 |
368,923 |
0.26% |
-2,896,000 |
0 |
0.155 |
N/A |
|
|
NRIX |
Nurix Therapeutics, Inc. |
38 |
- |
$0.00 |
$35,871,000 |
3,882,125 |
0.26% |
-8,346,000 |
0 |
4.371 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
39 |
- |
$0.70 |
$31,077,000 |
789,759 |
0.23% |
16,364,000 |
0 |
1.583 |
N/A |
|
|
TRDA |
Entrada Therapeutics, Inc. |
40 |
- |
$0.00 |
$28,222,000 |
4,865,819 |
0.2% |
-4,476,000 |
0 |
15.59 |
N/A |
|
|
ARGX |
Argenx Se |
41 |
- |
$901.17 |
$27,850,000 |
37,760 |
0.2% |
7,036,000 |
0 |
0.08 |
N/A |
|
|
RNA |
Avidity Biosciences, Inc. |
42 |
New |
$71.63 |
$27,231,000 |
625,000 |
0.2% |
27,231,000 |
625,000 |
0.366 |
N/A |
|
|
PCVX |
Vaxcyte, Inc. |
43 |
- |
$0.00 |
$23,085,000 |
640,885 |
0.17% |
2,250,000 |
0 |
0.05 |
N/A |
|
|
IRON |
Disc Medicine, Inc |
44 |
- |
$93.26 |
$22,272,000 |
337,050 |
0.16% |
4,422,000 |
0 |
0.967 |
N/A |
|
|
CDTX |
Cidara Therapeutics, Inc. |
45 |
- |
$220.36 |
$21,764,000 |
227,272 |
0.16% |
10,694,000 |
0 |
0.68 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
46 |
- |
$29.45 |
$17,213,000 |
665,370 |
0.12% |
3,673,000 |
0 |
0.902 |
Diagnostic Substances |
|
|
NGNE |
Neurogene |
47 |
- |
$3.68 |
$17,186,000 |
991,691 |
0.12% |
2,360,000 |
0 |
2.367 |
N/A |
|
|
SERA |
Sera Prognostics, Inc. |
48 |
- |
$3.08 |
$16,824,000 |
5,498,170 |
0.12% |
1,594,000 |
0 |
18.772 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
49 |
- |
$0.60 |
$16,760,000 |
1,000,000 |
0.12% |
7,378,000 |
373,297 |
1.557 |
N/A |
|
|
CERS |
Cerus Corp |
50 |
- |
$2.07 |
$15,913,000 |
10,008,345 |
0.12% |
-2,253,000 |
-2,875,499 |
5.988 |
Biotechnology |
|
|
AKRO |
Akero Therapeutics, Inc. |
51 |
- |
$0.00 |
$15,413,000 |
324,630 |
0.11% |
-1,909,000 |
0 |
0.341 |
N/A |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
52 |
- |
$0.00 |
$14,864,000 |
370,208 |
0.11% |
3,276,000 |
0 |
0.431 |
N/A |
|
|
DBVT |
DBV Technologies SA |
53 |
- |
$0.61 |
$14,614,000 |
1,461,425 |
0.11% |
1,227,000 |
0 |
5.813 |
N/A |
|
|
PRLD |
Prelude Therapeutics Inc |
54 |
- |
$0.00 |
$14,578,000 |
10,123,824 |
0.11% |
6,384,000 |
0 |
23.167 |
N/A |
|
|
ACLX |
Arcellx, Inc. |
55 |
- |
$0.00 |
$13,696,000 |
166,825 |
0.1% |
2,711,000 |
0 |
0.258 |
N/A |
|
|
CTMX |
Cytomx Therapeutics, Inc. |
56 |
- |
$0.00 |
$13,560,000 |
4,250,826 |
0.1% |
5,651,000 |
766,600 |
2.578 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
57 |
- |
$0.00 |
$13,096,000 |
4,004,756 |
0.09% |
3,845,000 |
0 |
1.468 |
N/A |
|
|
XNCR |
Xencor Inc |
58 |
- |
$17.30 |
$12,928,000 |
1,102,106 |
0.09% |
7,658,000 |
431,675 |
1.225 |
Biotechnology |
|
|
DSGN |
Design Therapeutics, Inc. |
59 |
- |
$0.00 |
$12,898,000 |
1,712,882 |
0.09% |
7,126,000 |
0 |
3.08 |
N/A |
|
|
NUVL |
Nuvalent, Inc. |
60 |
- |
$0.00 |
$12,448,000 |
143,937 |
0.09% |
1,466,000 |
0 |
0.196 |
N/A |
|
|
SION |
Sionna Therapeutics, Inc. |
61 |
- |
$0.00 |
$11,764,000 |
400,000 |
0.09% |
4,824,000 |
0 |
0.907 |
N/A |
|
|
CRNX |
Crinetics Pharmaceuticals, ... |
62 |
- |
$46.67 |
$11,662,000 |
280,000 |
0.08% |
3,609,000 |
0 |
0.262 |
N/A |
|
|
VKTX |
Viking Therapeutics, Inc. |
63 |
New |
$38.55 |
$9,621,000 |
366,083 |
0.07% |
9,621,000 |
366,083 |
0.364 |
N/A |
|
|
PHVS |
Pharvaris N V Ord Shs |
64 |
New |
$0.00 |
$9,356,000 |
375,000 |
0.07% |
9,356,000 |
375,000 |
0.091 |
N/A |
|
|
AGIO |
Agios Pharmaceuticals Inc |
65 |
- |
$27.73 |
$7,621,000 |
189,866 |
0.06% |
1,306,000 |
0 |
0.275 |
N/A |
|
|
SANA |
Sana Biotechnology, Inc. |
66 |
- |
$0.00 |
$7,210,000 |
2,030,949 |
0.05% |
1,666,000 |
0 |
1.083 |
N/A |
|
|
SGMT |
Sagimet Biosciences Inc. |
67 |
- |
$6.39 |
$6,538,000 |
952,996 |
0.05% |
-724,000 |
0 |
4.462 |
N/A |
|
|
ALMS |
Alumis Inc. |
68 |
- |
$11.12 |
$6,234,000 |
1,562,500 |
0.05% |
1,546,000 |
0 |
1.502 |
N/A |
|
|
RLAY |
Relay Therapeutics, Inc. |
69 |
- |
$7.68 |
$6,056,000 |
1,160,117 |
0.04% |
2,042,000 |
0 |
0.673 |
N/A |
|
|
SKYE |
Skye Bioscience Inc |
70 |
- |
$1.20 |
$5,701,000 |
1,450,638 |
0.04% |
-363,000 |
0 |
5.168 |
N/A |
|
|
HRTX |
Heron Therapeutics Inc |
71 |
New |
$1.31 |
$5,357,000 |
4,251,951 |
0.04% |
5,357,000 |
4,251,951 |
2.803 |
Synthetics |
|
|
TCRX |
Tscan Therapeutics, Inc. |
72 |
- |
$0.00 |
$5,068,000 |
2,784,792 |
0.04% |
1,030,000 |
0 |
6.394 |
N/A |
|
|
MBX |
Mbx Biosciences, Inc. |
73 |
New |
$0.00 |
$4,861,000 |
277,777 |
0.04% |
4,861,000 |
277,777 |
0.506 |
N/A |
|
|
VTVT |
Vtv Therapeutics Inc. |
74 |
- |
$0.35 |
$3,463,000 |
148,314 |
0.03% |
2,003,000 |
51,000 |
0.332 |
N/A |
|
|
VTYX |
Ventyx Biosciences, Inc. |
75 |
New |
$8.72 |
$3,182,000 |
1,023,130 |
0.02% |
3,182,000 |
1,023,130 |
1.448 |
N/A |
|
|
LBRX |
Lb Pharmaceuticals Inc |
|
New |
$19.50 |
$3,158,000 |
200,000 |
0.02% |
3,158,000 |
200,000 |
0.791 |
N/A |
|
|
VIR |
Vir Biotechnology, Inc. |
76 |
- |
$0.00 |
$3,098,000 |
542,539 |
0.02% |
364,000 |
0 |
0.426 |
N/A |
|
|
WVE |
Wave Life Sciences Ltd. |
77 |
- |
$7.49 |
$2,519,000 |
344,063 |
0.02% |
283,000 |
0 |
0.223 |
N/A |
|
|
ELVN |
Enliven Therapeutics Ord Shs |
78 |
- |
$0.00 |
$2,351,000 |
114,833 |
0.02% |
47,000 |
0 |
0.185 |
N/A |
|
|
TARA |
Protara Therapeutics, Inc |
79 |
- |
$5.58 |
$2,335,000 |
536,832 |
0.02% |
708,000 |
0 |
1.391 |
N/A |
|
|
TECX |
Tectonic Therapeutic Inc |
80 |
- |
$19.92 |
$1,569,000 |
100,000 |
0.01% |
-418,000 |
0 |
0.679 |
N/A |
|
|
KALA |
Kala Pharmaceuticals, Inc. |
81 |
- |
$0.90 |
$1,507,000 |
985,093 |
0.01% |
-4,214,000 |
-216,801 |
21.369 |
N/A |
|
|
GBIO |
Generation Bio Co. |
82 |
- |
$0.00 |
$1,190,000 |
194,493 |
0.01% |
567,000 |
-1,750,452 |
0.327 |
N/A |
|
|
CTNM |
Contineum Therapeutics, Inc. |
83 |
- |
$11.04 |
$913,000 |
77,670 |
0.01% |
-328,000 |
-234,830 |
0.302 |
N/A |
|
|
ALGS |
Aligos Therapeutics, Inc. |
84 |
- |
$0.00 |
$814,000 |
83,055 |
0.01% |
215,000 |
0 |
0.115 |
N/A |
|
|
VYNE |
VYNE Therapeutics Inc |
85 |
New |
$0.22 |
$285,000 |
851,353 |
0% |
285,000 |
851,353 |
1.659 |
N/A |
|
|
TYRA |
Tyra Biosciences, Inc. |
86 |
- |
$0.00 |
$148,000 |
10,607 |
0% |
46,000 |
0 |
0.018 |
N/A |
|
|
ACRV |
Acrivon Therapeutics, Inc. |
87 |
- |
$2.37 |
$41,000 |
22,809 |
0% |
14,000 |
0 |
0.074 |
N/A |
|
|
SRZNW |
Surrozen Equity Warrant Exp... |
88 |
- |
$0.00 |
$15,000 |
833,333 |
0% |
0 |
0 |
9.259 |
N/A |
|
|
IGMS |
Igm Biosciences, Inc. |
92 |
Closed |
$0.00 |
$0 |
0 |
0% |
-4,588,000 |
-4,096,210 |
0 |
N/A |
|
|
FATE |
Fate Therapeutics Inc |
94 |
Closed |
$1.08 |
$0 |
0 |
0% |
-2,783,000 |
-2,485,018 |
0 |
Biotechnology |
|
|
NMRA |
Neumora Therapeutics, Inc. |
91 |
Closed |
$2.22 |
$0 |
0 |
0% |
-759,000 |
-1,034,600 |
0 |
N/A |
|
|
RCKT |
Rocket Pharmaceuticals |
90 |
Closed |
$3.32 |
$0 |
0 |
0% |
-1,353,000 |
-552,079 |
0 |
N/A |
|
|
BPMC |
Blueprint Medicines Corp |
93 |
Closed |
$129.46 |
$0 |
0 |
0% |
-16,091,000 |
-125,538 |
0 |
N/A |
|
|
VERV |
Verve Therapeutics, Inc. |
97 |
Closed |
$0.00 |
$0 |
0 |
0% |
-18,996,000 |
-1,691,530 |
0 |
N/A |
|
|
CADL |
Candel Therapeutics, Inc. |
98 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,797,000 |
-355,112 |
0 |
N/A |
|
|
HOOK |
Hookipa Pharma Inc. |
96 |
Closed |
$0.89 |
$0 |
0 |
0% |
-1,020,000 |
-812,814 |
0 |
N/A |
|
|
OPT |
Opthea Ltd |
89 |
- |
$0.05 |
$0 |
2,087,320 |
0% |
0 |
0 |
4.945 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
95 |
Closed |
$0.00 |
$0 |
0 |
0% |
-21,171,000 |
-223,843 |
0 |
N/A |
|
